Go Deep
Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 20,003 | 13.0 | 2.35 | 0.16 | 3,890.58 |
| Oct 2026 | 20,287 | 12.3 | 2.23 | 0.16 | 3,660.16 |
| Oct 2026 | 20,540 | 11.9 | 2.16 | 0.16 | 3,526.50 |
| Oct 2026 | 20,471 | 12.1 | 2.19 | 0.16 | 3,561.48 |
| Oct 2026 | 20,361 | 12.2 | 2.23 | 0.16 | 3,634.16 |
| Oct 2026 | 20,407 | 12.2 | 2.21 | 0.16 | 3,594.43 |
| Oct 2026 | 20,466 | 12.1 | 2.19 | 0.16 | 3,559.41 |
| Oct 2026 | 20,299 | 12.5 | 2.25 | 0.16 | 3,669.39 |
| Oct 2026 | 20,355 | 12.4 | 2.23 | 0.16 | 3,623.44 |
| Oct 2026 | 20,684 | 11.6 | 2.10 | 0.16 | 3,400.90 |
Harmony Biosciences Holdings, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 261,280,000.0 | 215,387,000.0 | 243,776,000.0 | 239,455,000.0 |
| Net Profit | 75,431,000.0 | 32,488,000.0 | 22,486,000.0 | 50,865,000.0 |
| EPS | 1.3 | 0.6 | 0.4 | 0.9 |
Harmony Biosciences Holdings, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 868,453,000.0 | 714,734,000.0 | 582,022,000.0 | 437,855,000.0 | — |
| Net Profit | 158,687,000.0 | 145,493,000.0 | 128,853,000.0 | 181,468,000.0 | — |
| EPS | 2.8 | 2.6 | 2.2 | 3.1 | — |
Harmony Biosciences Holdings, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 1,271,631,000.0 | 999,200,000.0 | 811,448,000.0 | 673,870,000.0 | — |
| Total Liabilities | 401,413,000.0 | 340,045,000.0 | 344,456,000.0 | 271,032,000.0 | — |
| Total Equity | 870,218,000.0 | 659,155,000.0 | 466,992,000.0 | 402,838,000.0 | — |
Owes vs Owns
Harmony Biosciences Holdings, Inc. owed $0.27 for every $1 it owned in Jun 2026, down from $0.40 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.27× | 0.32× | 0.34× | 0.42× | 0.40× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
Harmony Biosciences Holdings, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 61.0%Receivables 7.6%Intangible assets 7.0%Long-term investments 8.4%Other assets 15.5%
How it's funded — Dec 2025
Short-term debt 1.6%Long-term debt 11.3%Payables 1.4%Other liabilities 17.3%Shareholders' equity 68.4%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 775.3 | 467.2 | 353.5 | 323.1 |
| Receivables | 96.8 | 83.0 | 74.1 | 54.7 |
| Inventory | 5.4 | 7.2 | 5.4 | 4.3 |
| Fixed assets (tangible) | 0.0 | 1.3 | 0.4 | 0.6 |
| Intangible assets | 89.4 | 113.3 | 137.1 | 161.0 |
| Long-term investments | 107.1 | 108.9 | 72.2 | 22.6 |
| Other assets | 197.6 | 218.4 | 168.8 | 107.6 |
| Liabilities & equity | ||||
| Short-term debt | 20.0 | 16.2 | 15.0 | 2.0 |
| Long-term debt | 143.7 | 163.0 | 178.6 | 189.6 |
| Payables | 17.7 | 13.7 | 17.7 | 3.8 |
| Other liabilities | 220.1 | 147.0 | 133.2 | 75.6 |
| Shareholders' equity | 870.2 | 659.2 | 467.0 | 402.8 |
| Net tangible assets | 780.8 | 545.9 | 329.9 | 241.9 |
Harmony Biosciences Holdings, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 348,199,000.0 | 219,821,000.0 | 219,387,000.0 | 144,466,000.0 | — |
| Investing Activities | -39,649,000.0 | -67,484,000.0 | -46,439,000.0 | -141,832,000.0 | — |
| Financing Activities | -9,049,000.0 | -10,996,000.0 | -105,552,000.0 | 6,841,000.0 | — |